Novo Nordisk’s Pipeline and Buyback Offer Twin Props as Wegovy Prescriptions Cool
For Novo Nordisk, the contrast between long-term promise and near-term pressure has rarely been starker. On one side,…
Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 7, 2026 /PRNewswire/ — Novo Nordisk today announced Wegovy® (semaglutide) tablets 25…
Lilly’s obesity pill records modest second week as battle with Novo intensifies
By Sriparna Roy April 24 (Reuters) – Eli Lilly’s newly launched weight-loss pill had a modest second week,…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says Proactive uses…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says Proactive uses…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy continues to outpace its main competitor despite a slight weekly…